SCHEMBL24635646

SCHEMBL24635646

CCc1cccc(NC(C)CNC)c1C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.33
GABRB2 P47870 2/20 0.33
POLB P06746 2/20 0.33
ALDH1A1 P00352 2/20 0.33
PTGS2 P35354 1/20 0.33
CLCN2 P51788 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TAAR1 Q96RJ0 1/20 0.33
KCNH2 Q12809 2/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
SLC6A3 Q01959 1/20 0.32
ELANE P08246 2/20 0.31
NLRP3 Q96P20 1/20 0.31
TAS1R3 Q7RTX0 1/20 0.31
TAS1R1 Q7RTX1 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24635574 0.85 ALDH1A1 (0.41) POLBALDH1A1L3MBTL1TAAR1KCNH2
SCHEMBL24635664 0.84 DHFR (0.36) GABRA1GABRB2POLBALDH1A1CLCN2
SCHEMBL24635669 0.81 KEAP1 (0.41) POLBALDH1A1PTGS2TAAR1CYP3A4
SCHEMBL15516016 0.79 KDM4E (0.43) ALDH1A1L3MBTL1CYP2D6NLRP3GAA
SCHEMBL19993050 0.75 GABRA1 (0.43) GABRA1GABRB2POLBALDH1A1PTGS2
SCHEMBL27360925 0.74 MAPT (0.45) ALDH1A1TAAR1SLC6A2SLC6A4GAA
SCHEMBL29467778 0.71 ALDH1A1 (0.52) ALDH1A1L3MBTL1CYP3A4ELANEMAPT
SCHEMBL20059276 0.69 TAAR1 (0.46) GABRA1GABRB2TAAR1KCNH2CYP2D6
SCHEMBL11169978 0.68 MAPT (0.45) POLBALDH1A1PTGS2L3MBTL1CYP3A4
SCHEMBL599099 0.67 GABRA1 (0.57) GABRA1GABRB2L3MBTL1TAAR1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022226408-A1 NOVEL ERGOLINES AND METHODS OF TREATING MOOD DISORDERS GILGAMESH PHARMACEUTICALS, INC. (US) 2022-10-27 WO disclosed